PPARGC1A and Parkinson disease: In Parkinson’s disease (PD), astrocytic mitochondrial dysfunction—linked to impaired PGC-1α signaling and reduced Nrf2-mediated antioxidant defense—exacerbates oxidative stress and accelerates dopaminergic neuron loss in the substantia nigra.